1. Home
  2. ABP vs USAS Comparison

ABP vs USAS Comparison

Compare ABP & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • USAS
  • Stock Information
  • Founded
  • ABP 2004
  • USAS 1998
  • Country
  • ABP United States
  • USAS Canada
  • Employees
  • ABP N/A
  • USAS N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • USAS Metal Mining
  • Sector
  • ABP Health Care
  • USAS Basic Materials
  • Exchange
  • ABP Nasdaq
  • USAS Nasdaq
  • Market Cap
  • ABP 78.8M
  • USAS 122.4M
  • IPO Year
  • ABP N/A
  • USAS N/A
  • Fundamental
  • Price
  • ABP $3.01
  • USAS $0.38
  • Analyst Decision
  • ABP
  • USAS Strong Buy
  • Analyst Count
  • ABP 0
  • USAS 1
  • Target Price
  • ABP N/A
  • USAS $0.80
  • AVG Volume (30 Days)
  • ABP 1.9M
  • USAS 676.1K
  • Earning Date
  • ABP 02-18-2025
  • USAS 11-07-2024
  • Dividend Yield
  • ABP N/A
  • USAS N/A
  • EPS Growth
  • ABP N/A
  • USAS N/A
  • EPS
  • ABP N/A
  • USAS N/A
  • Revenue
  • ABP $122,000.00
  • USAS $97,123,000.00
  • Revenue This Year
  • ABP N/A
  • USAS $21.84
  • Revenue Next Year
  • ABP N/A
  • USAS $46.00
  • P/E Ratio
  • ABP N/A
  • USAS N/A
  • Revenue Growth
  • ABP N/A
  • USAS 14.33
  • 52 Week Low
  • ABP $0.95
  • USAS $0.20
  • 52 Week High
  • ABP $13.00
  • USAS $0.54
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • USAS 46.40
  • Support Level
  • ABP N/A
  • USAS $0.35
  • Resistance Level
  • ABP N/A
  • USAS $0.44
  • Average True Range (ATR)
  • ABP 0.00
  • USAS 0.03
  • MACD
  • ABP 0.00
  • USAS -0.00
  • Stochastic Oscillator
  • ABP 0.00
  • USAS 30.00

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.

Share on Social Networks: